Early diagnosis and risk factors of acute hepatitis C in high-risk MSM on preexposure prophylaxis.
Abstract
BACKGROUND: A high incidence of acute hepatitis C virus (HCV) (AHCV) infection has been reported among at-risk HIV-negative MSM. The optimal strategy for early diagnosis of AHCV in this population is not clearly defined. METHODS: In the ANRS IPERGAY PrEP trial, among high-risk HIV-negative MSM, HCV serology and serum alanine aminotransferase (ALT) were used for screening at enrollment and during follow-up. Behavioral risk factors were compared at baseline between participants who were diagnosed with AHCV during the study compared with those who did not. In participants with a positive HCV serology, we used stored sera to perform the following tests at diagnosis and on previous visits: HCV-antibodies rapid tests, plasma HCV viral load and HCV antigen immunoassay. We evaluated the sensitivity of each test for AHCV diagnosis. RESULTS: Among 429 enrolled participants, 14 were diagnosed with AHCV infection, with a median follow-up of 2.1 (interquartile range, 1.5-2.8) years. AHCV incidence was 1.40 per 100 person-years (95% confidence interval, 0.74-2.39). Patients with AHCV reported a significantly higher number of sexual acts and/or partners, and more frequent recreational drug use at baseline. At the prior visit before AHCV diagnosis (median of 2 months earlier), sensitivities of HCV RNA and HCV antigen tests were, respectively, 100 and 89%, whereas none of the patients had a positive serology, and only 25% had elevated ALT. CONCLUSION: HCV antigen and RNA tests were positive within a median of 2 months before the detection of antibodies and ALT elevation. These tests could be considered for HCV screening in high-risk MSM.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Acute HCV infections have been reported among MSM on PrEP, increasing concerns that certain MSM might be at increased risk for incident HCV infection through condomless sexual intercourse with MSM with HCV infection.
“More recently, acute HCV infections have been reported among MSM on PrEP, increasing concerns that certain MSM might be at increased risk for incident HCV infection through condomless sexual intercourse with MSM with HCV infection (1359,1360).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [1360]
Cites
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C. L., Gall, J.-M. L., Cua, É., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633 · see citing works
Self-citationEASL Recommendations on Treatment of Hepatitis C 2016
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 982 · see citing works
Panel, A.-I. H. G., Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K., Naggie, S., Vargas, H. E., Aronsohn, A. I., Bhattacharya, D., Broder, T., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy585 · Cited by 722 · see citing works
Molina, J.-M., Charreau, I., Spire, B., Cotte, L., Chas, J., Capitant, C., Tremblay, C., Rojas-Castro, D., Cua, E., Pasquet, A., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30089-9 · Cited by 472 · see citing works
Self-citationUS Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Curry, S. J., Doubeni, C. A., Epling, J. W., et al. (2019) · JAMA · doi:10.1001/jama.2019.6390 · Cited by 312 · see citing works
van de Laar, T. J. W., van der Bij, A. K., Prins, M., Bruisten, S. M., Brinkman, K., Ruys, T. A., van der Meer, J. T. M., Vries, H. J. C. D., Mulder, J., Agtmael, M. V., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/518796 · Cited by 284 · see citing works
Hagan, H., Jordan, A. E., Neurer, J., & Cleland, C. M. (2015) · AIDS · doi:10.1097/qad.0000000000000834 · Cited by 224 · see citing works
Boerekamps, A., van den Berk, G. E. L., Lauw, F. N., Leyten, E. M. S., van Kasteren, M. E. E., van Eeden, A., Posthouwer, D., Claassen, M. A. A., Dofferhoff, A. S. M., Verhagen, D. W. M., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1007 · Cited by 165 · see citing works
Yaphe, S., Bozinoff, N., Kyle, R., Shivkumar, S., Pai, N. P., & Klein, M. B. (2012) · Sexually Transmitted Infections · doi:10.1136/sextrans-2012-050566 · Cited by 163 · see citing works
Pavie, J., Rachline, A., Loze, B., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011581 · Cited by 148 · see citing works
The European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel (2010) · AIDS · doi:10.1097/qad.0b013e328343443b · Cited by 142 · see citing works
MSM starting preexposure prophylaxis are at risk of hepatitis C virus infection.
Hoornenborg, E., Achterbergh, R. C. A., Schim van der Loeff, M. F., Davidovich, U., Hogewoning, A., de Vries, H. J. C., Schinkel, J., Prins, M., & van de Laar, T. J. W. (2017) · AIDS · doi:10.1097/qad.0000000000001522 · Cited by 137 · see citing works
Vanhommerig, J. W., Lambers, F. A. E., Schinkel, J., Geskus, R. B., Arends, J. E., van de Laar, T. J. W., Lauw, F. N., Brinkman, K., Gras, L., Rijnders, B. J. A., et al. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv115 · Cited by 104 · see citing works
Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men
Charre, C., Cotte, L., Kramer, R., Miailhes, P., Godinot, M., Koffi, J., Scholtès, C., & Ramière, C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190340 · Cited by 65 · see citing works
Self-citationCotte, L., Cua, É., Reynes, J., Raffi, F., Rey, D., Delobel, P., Gagneux‐Brunon, A., Jacomet, C., Palich, R., Laroche, H., et al. (2018) · Liver International · doi:10.1111/liv.13922 · Cited by 64 · see citing works
Self-citationGupta, E., Agarwala, P., Kumar, G., et al. (2017) · Journal of Clinical Virology · doi:10.1016/j.jcv.2017.01.006 · Cited by 63 · see citing works
Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV
Pradat, P., Huleux, T., Raffi, F., Delobel, P., Valantin, M., Poizot‐Martin, I., Puglièse, P., Reynes, J., Rey, D., Hoen, B., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001789 · Cited by 58 · see citing works
Self-citationLarsen, C., Chaix, M., Strat, Y. L., Velter, A., Gervais, A., Aupérin, I., Alric, L., Duval, X., Miailhes, P., Pioche, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029322 · Cited by 52 · see citing works
Self-citationVolk, J. E., Marcus, J. L., Phengrasamy, T., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ129 · Cited by 51 · see citing works
Ireland, G., Higgins, S. P., Goorney, B. P., Ward, C. J., Ahmad, S. S. Y., Stewart, C. M. W., Simmons, R., Lattimore, S., & Lee, V. (2017) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052876 · Cited by 39 · see citing works
Lockart, I., Matthews, G. V., & Danta, M. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000515 · Cited by 37 · see citing works
Vanhommerig, J. W., van de Laar, T. J. W., KOOT, M., van Rooijen, M. S., Schinkel, J., Speksnijder, A. G. C. L., Prins, M., de Vries, H. J. C., & Bruisten, S. M. (2014) · Journal of Virological Methods · doi:10.1016/j.jviromet.2014.11.026 · Cited by 24 · see citing works
Hullegie, S. J., GeurtsvanKessel, C. H., van der Eijk, A. A., Ramakers, C., & Rijnders, B. J. A. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21621 · Cited by 22 · see citing works
Braun, D. L., Hampel, B., Martin, E. M., Kouyos, R. D., Kusejko, K., Grube, C., Flepp, M., Stöckle, M., Conen, A., Béguelin, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy545 · Cited by 18 · see citing works
Braun, D. L., Hampel, B., Martin, E., et al. (2019) · Open Access CRIS of the University of Bern · doi:10.7892/boris.119431 · Cited by 14 · see citing works
Nguyen, T., Delaugerre, C., Valantin, M., Amiel, C., Netzer, E., L’Yavanc, T., Ohayon, M., Valin, N., Day, N., Kreplak, G., et al. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002099 · Cited by 12 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 2,759 · see citing works
- Authors
- Gras, J., Mahjoub, N., Charreau, I., Cotte, L., Tremblay, C., Chas, J., Raffi, F., Cua, E., Guillon, B., Guigue, N., Chaix, M. L., Meyer, L., Molina, J. M., & Delaugerre, C.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hospices Civils de Lyon (FR)
- Université Paris-Sud (FR)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Gras, Julien
- ORCID
- Venue
- AIDS
- Published
- 2020-01-01
- Volume
- 34
- Issue
- 1
- Pages
- 47-52
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2972244319
- Cited by
- 28
- References
- 26
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4 · 2021: 6 · 2020: 8
- FWCI
- 2.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- AIDS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatitis C virus research
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- acute hepatitis C, hepatitis C virus, men who have sex with men, pre-exposure prophylaxis, HCV screening, HCV RNA testing, HCV serology, alanine aminotransferase, diagnostic sensitivity, risk factors, recreational drug use, sexual behavior, HIV-negative MSM
- MeSH terms
- Acute Disease, Adult, Alanine Transaminase, Hepatitis C, Humans, Male, Risk Factors, RNA, Viral, HIV Infections, Homosexuality, Male, Hepatitis C Antigens, Hepatitis C Antibodies, Viral Load, Early Diagnosis, Pre-Exposure Prophylaxis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review